| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $208,855,896 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R33HS030123 | ML-ROVER: Machine Learning to Reduce Laboratory Test Overutilization | 000 | 3 | AHRQ | 9/3/2026 | $252,658 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH140750 | A multi-level intervention to upscale HIV testing and PrEP uptake for men with high HIV exposure via community pharmacies in resource-limited settings | 002 | 1 | NIH | 9/10/2026 | $171,909 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01HD119011 | A Process-Oriented Analysis of the Mechanisms and Conditions Underpinning Children's Vulnerability to Disorganized, Unpredictable Interparental Conflict | 000 | 1 | NIH | 8/27/2026 | $588,905 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH140750 | A multi-level intervention to upscale HIV testing and PrEP uptake for men with high HIV exposure via community pharmacies in resource-limited settings | 001 | 1 | NIH | 9/10/2026 | $87,923 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01MH140750 | A multi-level intervention to upscale HIV testing and PrEP uptake for men with high HIV exposure via community pharmacies in resource-limited settings | 000 | 1 | NIH | 8/31/2026 | $446,515 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K01DA065706 | Leveraging adolescent plasticity mechanisms to enhance adult frontal dopaminergic circuit function | 000 | 1 | NIH | 4/21/2026 | $156,555 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21ES037489 | Influence of pregnancy and the gut microbiome on methylmercury metabolism and elimination in the mother and fetus | 000 | 1 | NIH | 2/23/2026 | $415,613 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31HL184422 | RNA Aptamers for RNA Drug Delivery to Cardiac Cells | 001 | 1 | NIH | 8/6/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31HL184422 | RNA Aptamers for RNA Drug Delivery to Cardiac Cells | 000 | 1 | NIH | 8/6/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | S10OD040250 | Pyrolysis-Gas Chromatography-Mass Spectrometer for Western New York | 000 | 1 | NIH | 7/8/2026 | $529,333 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21AR086811 | Role of Telocytes in the Synovial Lymphatic System | 000 | 1 | NIH | 4/28/2026 | $342,125 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01HL184442 | Protective mechanisms in lung vascular injury | 000 | 1 | NIH | 8/27/2026 | $717,611 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31LM015310 | Interferon response digital twin for treatment in systemic lupus erythematosus. | 000 | 1 | NIH | 8/25/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21DE035245 | Array-Based Innervated salivary gland microphysiologic system | 000 | 1 | NIH | 7/8/2026 | $415,813 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 006 | 1 | NIH | 9/15/2026 | $6,995 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 005 | 1 | NIH | 9/14/2026 | $11,873 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R13ES038760 | Measuring Micro and Nanoplastics in Environmental Samples Workshop | 000 | 1 | NIH | 4/28/2026 | $24,000 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01HL178616 | Establishing the role of exercise in the maintenance of a cardioprotective stress response | 000 | 1 | NIH | 7/8/2026 | $665,724 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F32GM167162 | Elucidating the mechanisms of FMRP-mediated translation repression through structural and biochemical analyses of FMRP-bound mRNPs | 000 | 1 | NIH | 8/26/2026 | $76,300 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 004 | 1 | NIH | 9/11/2026 | $15,891 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 003 | 1 | NIH | 9/10/2026 | $12,160 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 002 | 1 | NIH | 9/9/2026 | $39,157 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 001 | 1 | NIH | 9/8/2026 | $8,952 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R34AI198088 | Aggressive antipyretics for neuroprotection and mortality reduction in CNS malaria: A Randomized-Controlled Trial | 000 | 1 | NIH | 8/27/2026 | $151,572 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | F31AI202950 | The human Integrator complex is required for Herpes Simplex Virus Type 1 infection | 000 | 1 | NIH | 8/12/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01CA309279 | Emerging nicotine analogs and device design characteristics on toxicity assessment | 000 | 1 | NIH | 8/13/2026 | $583,304 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K23AG086622 | Efficacy of Dyadic Life Review Therapy for Distressed Caregivers of Older Patients with Alzheimer's Disease and Related Dementias (ADRD) and Advanced Cancer | 000 | 1 | NIH | 8/4/2026 | $188,445 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AG097446 | ORAI Channels and Neurovascular Coupling: Effects of Aging | 000 | 1 | NIH | 9/10/2026 | $560,891 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K01HD120749 | Maternal History of Childhood Maltreatment and Perinatal Cardiometabolic Health | 000 | 1 | NIH | 9/17/2026 | $130,072 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AG097531 | Leveraging Data Linkages to Evaluate the Effects of a Geriatric Assessment Oncology Care Model in Older Adults with Advanced Cancer | 000 | 1 | NIH | 9/3/2026 | $635,825 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R03AG101174 | The role of positive emotions in stress-induced negative emotion regulation among older adults with mild cognitive impairment | 000 | 1 | NIH | 9/16/2026 | $302,084 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21HD123838 | Developing and Validating a Computational Phenotype for Perimenopause in Large-Scale Electronic Health Records | 000 | 1 | NIH | 9/4/2026 | $416,106 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21GM166477 | Contactless activation of the mechanosensory system by photoacoustic stimulation | 000 | 1 | NIH | 9/3/2026 | $399,475 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AG082992 | Family care to nursing home residents and state essential caregiver programs during 2020-2021: impact on dementia care outcomes | 000 | 2 | NIH | 9/11/2026 | $355,824 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DC023352 | Mammalian bile acid chemosensation and its role in social assessment | 000 | 1 | NIH | 9/11/2026 | $637,244 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K99AG102010 | Optical Modulation of Quantum Nanomaterial Surface Chemistries to Functionally Mimic Amyloidogenic Protein Assemblies | 000 | 1 | NIH | 9/11/2026 | $128,327 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | H79SM092300 | UR-Supporting Our Students: Connecting Adolescents to Resources and Evidence-Based Supports (UR-SOS CARES) | 000 | 1 | SAMHSA | 9/16/2026 | $200,000 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01HD122308 | Identifying the Susceptibility Mechanisms Accounting for the Moderating Role of Children's Environmental Sensitivity to Family Interaction Dynamics | 001 | 1 | NIH | 6/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01HD122308 | Identifying the Susceptibility Mechanisms Accounting for the Moderating Role of Children's Environmental Sensitivity to Family Interaction Dynamics | 000 | 1 | NIH | 6/23/2026 | $580,341 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | K99CA308581 | A combined exercise and nutrition intervention to treat cancer-related fatigue, unhealthy weight gain, and impaired physical function | 000 | 1 | NIH | 7/6/2026 | $133,510 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01HL174537 | PKD3 and Valvular Heart Disease | 000 | 1 | NIH | 8/19/2026 | $2,382,189 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01DE035845 | Develop an AI-Powered Digital Platform for Remote Oral Disease Detection and Prediction | 000 | 1 | NIH | 8/10/2026 | $642,037 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R35GM161248 | Harnessing N-Aryl and N-Alkenyl Nitrogen Intermediates for Versatile C-N Bond Formation | 000 | 1 | NIH | 8/21/2026 | $448,196 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R01AG096598 | The Effects of Declining Nursing Home Capacity on Post-Acute and Long-Term Care Access and Health Outcomes among Older Adults and their Caregivers | 001 | 2 | NIH | 6/11/2026 | $596,038 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21AG103392 | Longitudinal Intravital Multiphoton Imaging of the Murine Intervertebral Disc to Reveal Age-Associated Mechanisms of Degeneration | 000 | 1 | NIH | 8/10/2026 | $599,180 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21CA300890 | Transcriptional co-activator PGC-1α promotes anti-tumor immunity in colorectal cancer | 001 | 1 | NIH | 8/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | RF1NS148111 | Spatiotemporal Control of Cerebral Blood Flow by Purinergic Signaling Networks | 000 | 1 | NIH | 6/12/2026 | $1,606,088 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21EB039495 | A Drug Development Tool for Assessing CRS and Neurotoxicity in Immunotherapy | 000 | 1 | NIH | 8/20/2026 | $226,625 |
| | 2026 | 2026 | UNIVERSITY OF ROCHESTER | 910 GENESEE ST | ROCHESTER | NY | 14611-3847 | MONROE | USA | R21DC023033 | Direct Assessment of Human Gravity Sensors to Improve Peripheral Vestibular Assessment | 000 | 1 | NIH | 6/8/2026 | $403,125 |
|
